Kilitch Drugs (India) Limited (NSE:KILITCH)
India
· Delayed Price · Currency is INR 409.45
+51.80 (14.48%)
Apr 29, 2025, 2:30 PM IST
Kilitch Drugs (India) Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2015 - 2019 |
| Revenue | 1,819 | 1,544 | 1,396 | 1,142 | 685.23 | 533.2 | Upgrade
|
| Revenue Growth (YoY) | 17.34% | 10.58% | 22.20% | 66.71% | 28.51% | -35.36% | Upgrade
|
| Cost of Revenue | 1,011 | 793.92 | 754.16 | 673.86 | 379.13 | 297.73 | Upgrade
|
| Gross Profit | 808.42 | 749.8 | 641.83 | 468.49 | 306.11 | 235.47 | Upgrade
|
| Selling, General & Admin | 299.48 | 239.66 | 231.58 | 117.14 | 97.23 | 113.6 | Upgrade
|
| Other Operating Expenses | 266.79 | 262.1 | 234.61 | 234.96 | 156.1 | 118.74 | Upgrade
|
| Operating Expenses | 589.77 | 526.82 | 493.27 | 368.33 | 264.76 | 243.91 | Upgrade
|
| Operating Income | 218.65 | 222.98 | 148.56 | 100.16 | 41.34 | -8.44 | Upgrade
|
| Interest Expense | -47.62 | -59.29 | -49.19 | -11.98 | -7.54 | -7.16 | Upgrade
|
| Interest & Investment Income | 4.2 | 4.2 | 3.1 | 2.5 | 2.26 | 2.73 | Upgrade
|
| Earnings From Equity Investments | 0.02 | 0.02 | 0.02 | -0.02 | -0.02 | -0.02 | Upgrade
|
| Currency Exchange Gain (Loss) | 19.96 | 19.96 | 15.6 | -2.29 | 9.76 | 17.75 | Upgrade
|
| Other Non Operating Income (Expenses) | 54.78 | 0.22 | 0.59 | 2.62 | 1.8 | 1.44 | Upgrade
|
| EBT Excluding Unusual Items | 249.98 | 188.09 | 118.69 | 90.98 | 47.59 | 6.3 | Upgrade
|
| Impairment of Goodwill | -8.43 | -8.43 | -8.43 | -8.43 | -8.43 | -8.43 | Upgrade
|
| Gain (Loss) on Sale of Investments | 13.89 | 13.89 | 9.88 | 13.59 | 12.03 | 18.19 | Upgrade
|
| Pretax Income | 255.44 | 193.55 | 120.14 | 96.14 | 51.2 | 16.07 | Upgrade
|
| Income Tax Expense | 75.25 | 57.79 | 37.32 | 34.01 | 13.53 | 7.65 | Upgrade
|
| Earnings From Continuing Operations | 180.19 | 135.75 | 82.83 | 62.14 | 37.67 | 8.42 | Upgrade
|
| Minority Interest in Earnings | 14.93 | 10.26 | 21.65 | 11.54 | -0.96 | - | Upgrade
|
| Net Income | 195.12 | 146.01 | 104.48 | 73.67 | 36.71 | 8.42 | Upgrade
|
| Net Income to Common | 195.12 | 146.01 | 104.48 | 73.67 | 36.71 | 8.42 | Upgrade
|
| Net Income Growth | 33.92% | 39.75% | 41.82% | 100.68% | 336.00% | -78.02% | Upgrade
|
| Shares Outstanding (Basic) | 16 | 16 | 16 | 16 | 15 | 15 | Upgrade
|
| Shares Outstanding (Diluted) | 16 | 16 | 16 | 16 | 15 | 15 | Upgrade
|
| Shares Change (YoY) | 1.67% | 2.23% | 0.10% | 0.56% | 0.37% | 5.08% | Upgrade
|
| EPS (Basic) | 12.14 | 9.17 | 6.71 | 4.73 | 2.37 | 0.55 | Upgrade
|
| EPS (Diluted) | 12.14 | 9.17 | 6.71 | 4.73 | 2.37 | 0.55 | Upgrade
|
| EPS Growth | 31.72% | 36.71% | 41.76% | 99.58% | 334.09% | -79.08% | Upgrade
|
| Free Cash Flow | - | -65.97 | -12.26 | -24.19 | 93.61 | -60.38 | Upgrade
|
| Free Cash Flow Per Share | - | -4.14 | -0.79 | -1.55 | 6.05 | -3.92 | Upgrade
|
| Gross Margin | 44.44% | 48.57% | 45.98% | 41.01% | 44.67% | 44.16% | Upgrade
|
| Operating Margin | 12.02% | 14.44% | 10.64% | 8.77% | 6.03% | -1.58% | Upgrade
|
| Profit Margin | 10.73% | 9.46% | 7.48% | 6.45% | 5.36% | 1.58% | Upgrade
|
| Free Cash Flow Margin | - | -4.27% | -0.88% | -2.12% | 13.66% | -11.33% | Upgrade
|
| EBITDA | 240.41 | 246.97 | 175.51 | 116.29 | 52.75 | 3.11 | Upgrade
|
| EBITDA Margin | 13.22% | 16.00% | 12.57% | 10.18% | 7.70% | 0.58% | Upgrade
|
| D&A For EBITDA | 21.76 | 23.99 | 26.96 | 16.13 | 11.41 | 11.55 | Upgrade
|
| EBIT | 218.65 | 222.98 | 148.56 | 100.16 | 41.34 | -8.44 | Upgrade
|
| EBIT Margin | 12.02% | 14.44% | 10.64% | 8.77% | 6.03% | -1.58% | Upgrade
|
| Effective Tax Rate | 29.46% | 29.86% | 31.06% | 35.37% | 26.43% | 47.61% | Upgrade
|
| Revenue as Reported | 1,918 | 1,589 | 1,425 | 1,171 | 711.91 | 574.46 | Upgrade
|
| Advertising Expenses | - | - | - | - | - | 11.89 | Upgrade
|
Updated Feb 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.